A study from 2010 [104] showed that miR-143 was downregulated in osteosarcoma cell lines and tumor samples, and its levels of restoration allowed a direct targeting of Bcl-2, reducing cell viability and promoting apoptosis. The gene discussed is BCL2; the disease is neoplasm.